Prognostic significance of inflammation in patients with coronary artery disease at low residual inflammatory risk

[1]  Rongrong Yang,et al.  Relationship Between Monocyte-to-Lymphocyte Ratio as Well as Other Leukocyte-Derived Ratios and Carotid Plaques in Patients with Coronary Heart Disease: A RCSCD-TCM Study , 2022, Journal of inflammation research.

[2]  P. Jankowski,et al.  Investigation of the Associations of Novel Inflammatory Biomarkers—Systemic Inflammatory Index (SII) and Systemic Inflammatory Response Index (SIRI)—With the Severity of Coronary Artery Disease and Acute Coronary Syndrome Occurrence , 2022, International journal of molecular sciences.

[3]  A. Manolis,et al.  Low serum albumin: A neglected predictor in patients with cardiovascular disease. , 2022, European journal of internal medicine.

[4]  M. Michalak,et al.  Neutrophil Counts, Neutrophil-to-Lymphocyte Ratio, and Systemic Inflammatory Response Index (SIRI) Predict Mortality after Off-Pump Coronary Artery Bypass Surgery , 2022, Cells.

[5]  M. Dichgans,et al.  Targeting the CCL2-CCR2 axis for atheroprotection. , 2022, European heart journal.

[6]  W. Koenig,et al.  Targeted proteomics improves cardiovascular risk prediction in secondary prevention , 2022, European heart journal.

[7]  Hao Li,et al.  The Contribution of Inflammation to Stroke Recurrence Attenuates at Low LDL-C Levels , 2022, Journal of atherosclerosis and thrombosis.

[8]  A. Murphy,et al.  Neutrophils in cardiovascular disease: Warmongers, peacemakers or both? , 2021, Cardiovascular research.

[9]  H. Medbury,et al.  Nature versus Number: Monocytes in Cardiovascular Disease , 2021, International journal of molecular sciences.

[10]  L. Fan,et al.  A Correlation Between Monocyte to Lymphocyte Ratio and Long-Term Prognosis in Patients With Coronary Artery Disease After PCI , 2021, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[11]  J. Cornel,et al.  Colchicine Attenuates Inflammation Beyond the Inflammasome in Chronic Coronary Artery Disease: A LoDoCo2 Proteomic Substudy. , 2020, Circulation.

[12]  P. Libby,et al.  Low‐Dose Methotrexate for the Prevention of Atherosclerotic Events , 2019, The New England journal of medicine.

[13]  Lawrence A Leiter,et al.  Inflammatory and Cholesterol Risk in the FOURIER Trial , 2018, Circulation.

[14]  P. Libby,et al.  Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial , 2017, The Lancet.

[15]  C. Ozturk,et al.  The platelet-lymphocyte ratio: A simple, inexpensive and rapid prognostic marker for cardiovascular events , 2015, Platelets.

[16]  G. Kōsaki,et al.  [Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients]. , 1984, Nihon Geka Gakkai zasshi.